首页|期刊导航|中华医学杂志(英文版)|Patients with breath test positive are necessary to be identified from irritable bowel syndrome:a clinical trial based on microbiomics and rifaximin sensitivity
Patients with breath test positive are necessary to be identified from irritable bowel syndrome:a clinical trial based on microbiomics and rifaximin sensitivity
Zuojing Liu Yuan Fang Lijin Song Chen Zhou Heqing Tao John Y Kao Huaiqiu Zhu Chung Owyang Liping Duan Shiwei Zhu Meibo He Mo Li Hui Wei Lu Zhang Qinghua Sun Qiong Jia Nan Hu
中华医学杂志(英文版)2022,Vol.135Issue(14):1716-1727,12.
中华医学杂志(英文版)2022,Vol.135Issue(14):1716-1727,12.DOI:10.1097/CM9.0000000000002294
Patients with breath test positive are necessary to be identified from irritable bowel syndrome:a clinical trial based on microbiomics and rifaximin sensitivity
Patients with breath test positive are necessary to be identified from irritable bowel syndrome:a clinical trial based on microbiomics and rifaximin sensitivity
摘要
关键词
Irritable bowel syndrome/Small intestinal bacterial overgrowth/Breath test/Gut microbiota/RifaximinKey words
Irritable bowel syndrome/Small intestinal bacterial overgrowth/Breath test/Gut microbiota/Rifaximin引用本文复制引用
Zuojing Liu,Yuan Fang,Lijin Song,Chen Zhou,Heqing Tao,John Y Kao,Huaiqiu Zhu,Chung Owyang,Liping Duan,Shiwei Zhu,Meibo He,Mo Li,Hui Wei,Lu Zhang,Qinghua Sun,Qiong Jia,Nan Hu..Patients with breath test positive are necessary to be identified from irritable bowel syndrome:a clinical trial based on microbiomics and rifaximin sensitivity[J].中华医学杂志(英文版),2022,135(14):1716-1727,12.基金项目
The studies were supported by the National Natural Science Foundation of China(No.81670491)and the Michigan Medicine-PKUHSC Joint Institute for Transla-tional and Clinical Research(No.BMU20140478). (No.81670491)